Opportunity Information: Apply for CDC RFA GH15 151004CONT18
The grant opportunity titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR" is a continuation funding announcement from the Centers for Disease Control and Prevention (CDC), specifically within CDCs Center for Global Health (CGH). It is tied to the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) and focuses on strengthening HIV programming for key populations in Central America across the full service continuum, from prevention activities through linkage to care, treatment initiation, and sustained retention in care.
This is not an open competition. The opportunity is explicitly labeled as continuation funding and is intended only for organizations that previously received an award under the earlier related funding announcement, CDC-RFA-GH15-1510. In practice, that means eligibility is restricted to prior grantees from that earlier award, and new applicants should not expect to be considered. The funding mechanism is a cooperative agreement, which typically indicates substantial involvement by CDC in program direction, technical guidance, monitoring, and collaboration on implementation and evaluation, rather than a more hands-off relationship that is common with some standard grants.
Administratively, the opportunity is identified by Funding Opportunity Number CDC RFA GH15 151004CONT18, categorized under Health, with CFDA (assistance listing) number 93.067. The original closing date listed for the continuation action is November 30, 2017, and the record shows a creation date of August 30, 2017. The announcement does not specify an award ceiling (it is listed as 0), and the expected number of awards is not provided in the source data, which is common for continuation notices where funding levels and award counts are predetermined by existing project periods, performance, and available appropriations rather than competed anew.
Programmatically, the core intent is capacity building and service delivery strengthening for key populations, meaning groups that experience disproportionate HIV burden and/or barriers to services due to stigma, discrimination, criminalization, violence, or social marginalization. While the notice excerpt does not list specific populations, in PEPFAR HIV programming in Central America this usually refers to groups such as men who have sex with men, transgender people, sex workers, and others who face heightened HIV risk and reduced access to prevention, testing, and treatment services. The phrase "continuum from prevention to care and treatment" signals a comprehensive approach that aligns with global HIV strategies: improving prevention coverage, increasing HIV testing and case finding, ensuring rapid linkage to clinical care after diagnosis, supporting antiretroviral therapy initiation, and maintaining viral suppression through adherence and retention support.
Because it is a continuation, the underlying expectation is that previously funded partners will sustain and deepen ongoing work rather than launch entirely new initiatives. That typically includes consolidating systems that were built during the initial award, expanding effective interventions, improving quality of services, strengthening monitoring and evaluation, and ensuring that services are accessible and acceptable for key populations. The CDC role under a cooperative agreement often includes providing technical assistance on evidence-based interventions, program quality improvement, surveillance or strategic information, and ensuring alignment with PEPFAR requirements and country priorities.
In short, this opportunity is a CDC/PEPFAR continuation cooperative agreement meant to keep funding in place for existing grantees working in Central America to strengthen HIV prevention, testing, linkage, treatment, and retention services for key populations. It is designed to maintain momentum and build lasting capacity across the HIV service continuum rather than to solicit new applicants or start a new competitive funding cycle.Apply for CDC RFA GH15 151004CONT18
- The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on 2017-08-30.
- Applicants must submit their applications by 2017-11-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Building Capacity along the Continuum from Prevention to Care and Treatment for Key Populations in the Central America Region under PEPFAR."
Which agency is offering this funding?
This funding opportunity is offered by the Centers for Disease Control and Prevention (CDC), specifically through CDC's Center for Global Health (CGH).
Is this opportunity connected to PEPFAR?
Yes. The opportunity is tied to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and focuses on strengthening HIV programming in Central America.
Is this an open, competitive grant opportunity?
No. This is explicitly labeled as continuation funding and is not an open competition.
Who is eligible to apply?
Eligibility is restricted to organizations that previously received an award under the earlier related funding announcement, CDC-RFA-GH15-1510. New applicants should not expect to be considered.
What prior funding announcement does this continuation relate to?
This continuation funding is intended for prior awardees under CDC-RFA-GH15-1510.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH15 151004CONT18.
What is the CFDA/Assistance Listing number for this opportunity?
The CFDA (Assistance Listing) number provided is 93.067.
What type of funding mechanism is used?
The mechanism is a cooperative agreement, which generally indicates substantial CDC involvement in program direction, technical guidance, monitoring, and collaboration on implementation and evaluation.
What does a cooperative agreement imply for recipients?
Based on the description provided, a cooperative agreement implies that CDC is expected to be actively involved through technical assistance, program guidance, monitoring, and collaboration, rather than operating in a more hands-off role.
What is the main purpose of this continuation funding?
The core intent is to strengthen HIV programming for key populations in Central America across the full service continuum, from prevention activities through linkage to care, treatment initiation, and sustained retention in care.
What does "continuum from prevention to care and treatment" mean in this context?
It signals a comprehensive HIV approach that includes prevention coverage, HIV testing and case finding, rapid linkage to clinical care after diagnosis, support for antiretroviral therapy initiation, and retention/adherence support to maintain viral suppression.
What region does the program focus on?
The focus is on the Central America region.
Who are "key populations" as referenced in the opportunity?
The notice describes key populations as groups with disproportionate HIV burden and/or barriers to services due to factors such as stigma, discrimination, criminalization, violence, or social marginalization. The excerpt does not list specific groups, but it notes that in PEPFAR HIV programming in Central America this usually refers to groups such as men who have sex with men, transgender people, sex workers, and others who face heightened HIV risk and reduced access to services.
Does the announcement list specific key populations?
No. The excerpt does not list specific populations, though it provides typical examples commonly referenced in PEPFAR programming in Central America.
What kinds of activities are expected under this continuation?
Because it is continuation funding, the expectation is that previously funded partners will sustain and deepen ongoing work rather than launch entirely new initiatives. The description highlights strengthening service delivery and capacity building across prevention, testing, linkage to care, treatment initiation, and retention in care.
Is this funding intended to support new projects or to continue existing work?
It is intended to continue and strengthen existing work by previously funded partners, maintaining momentum and building lasting capacity rather than starting a new competitive cycle.
Does the opportunity mention monitoring and evaluation expectations?
Yes, at a high level. The description indicates CDC involvement in monitoring and collaboration on implementation and evaluation, and it notes that continuation work typically includes strengthening monitoring and evaluation and improving service quality.
Does the announcement specify an award ceiling?
No. The award ceiling is listed as 0 in the provided source data, which the description notes can occur in continuation notices where funding levels are predetermined by existing project periods, performance, and available appropriations.
Does the opportunity specify the expected number of awards?
No. The expected number of awards is not provided in the source data.
What are the key dates listed for this opportunity?
The record shows a creation date of August 30, 2017, and the original closing date listed for the continuation action is November 30, 2017.
What category is this opportunity listed under?
It is categorized under Health.
Why are new applicants not expected to be considered?
The opportunity is labeled continuation funding and is intended only for organizations that previously received an award under the earlier related funding announcement (CDC-RFA-GH15-1510), meaning it is not structured as an open competition.
How does CDC typically support recipients under this type of award?
As described, CDC support under the cooperative agreement often includes technical assistance on evidence-based interventions, program quality improvement, surveillance or strategic information, and alignment with PEPFAR requirements and country priorities.
What is the overall goal of this continuation opportunity in plain terms?
The goal is to keep funding in place for existing CDC/PEPFAR partners working in Central America to strengthen HIV prevention, testing, linkage, treatment, and retention services for key populations, with an emphasis on long-term capacity building across the HIV service continuum.
Browse more opportunities from the same category: Health
Next opportunity: Supporting Civil Society in Montenegro
Previous opportunity: Tracking the effects on vegetation and fuels of the 1947 Bar Harbor, Maine fire through time: 1948-2016
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 151004CONT18
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 151004CONT18) also looked into and applied for these:
| Funding Opportunity |
|---|
| Establishment of a Strategic Partnership to Strengthen the COMISCA under PEPFAR Apply for CDC RFA GH15 150904CONT18 Funding Number: CDC RFA GH15 150904CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01) Apply for PAR 17 466 Funding Number: PAR 17 466 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21) Apply for PAR 17 463 Funding Number: PAR 17 463 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21) Apply for PAR 17 474 Funding Number: PAR 17 474 Agency: National Institutes of Health Category: Health Funding Amount: $125,000 |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44) Apply for PAR 17 480 Funding Number: PAR 17 480 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44) Apply for PAR 17 479 Funding Number: PAR 17 479 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Repurposing Target-Based Pharmaceutical Libraries for Discovery of Therapeutics against Eukaryotic Pathogens (R21/R33) Apply for RFA AI 17 036 Funding Number: RFA AI 17 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 Clinical Trial Optional) Apply for RFA AI 17 028 Funding Number: RFA AI 17 028 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32) Apply for PA 17 481 Funding Number: PA 17 481 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Comparative Genomics Research Program (R01) Apply for PAR 17 482 Funding Number: PAR 17 482 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improved Quality and Sustainability of Medication Assisted Treatment in Ukraine under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 159403CONT18 Funding Number: CDC RFA GH15 159403CONT18 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25) Apply for PAR 17 485 Funding Number: PAR 17 485 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Accessible Continuum of Care and Essential Services Sustained (ACCESS) Apply for RFI 687 17 002 Funding Number: RFI 687 17 002 Agency: Madagascar USAID-Antananarivo Category: Health Funding Amount: $85,000,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R34) Apply for RFA RM 17 024 Funding Number: RFA RM 17 024 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (U01) Apply for RFA RM 17 023 Funding Number: RFA RM 17 023 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Science Education Partnership Award (SEPA) (R25) Apply for PAR 17 339 Funding Number: PAR 17 339 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Collaborative Centers (U54) Apply for RFA RM 17 020 Funding Number: RFA RM 17 020 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Science of Behavior Change: Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R21) Apply for RFA RM 17 028 Funding Number: RFA RM 17 028 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Science of Behavior Change: Revision Applications for Use-inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes (R01) Apply for RFA RM 17 022 Funding Number: RFA RM 17 022 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Human Heredity and Health in Africa (H3Africa): Ethical, Legal, and Societal Issues (ELSI) Research Program (U01) Apply for RFA RM 17 021 Funding Number: RFA RM 17 021 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 151004CONT18", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.